Dulla; Kalyana Chakravarthi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dulla; Kalyana Chakravarthi.The latest application filed is for "antisense oligonucleotides for the treatment of usher syndrome".
- Dulla; Kalyana Chakravarthi - Eindhoven N/A NL
- Dulla; Kalyana Chakravarthi - Leiden NL
| Patent | Date |
|---|---|
| Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression Grant 11,443,831 - Verhaegh , et al. September 13, 2 | 2022-09-13 |
| Antisense Oligonucleotides For The Treatment Of Usher Syndrome App 20220213478 - Swildens; Jim ; et al. | 2022-07-07 |
| Rna-editing Oligonucleotides For The Treatment Of Usher Syndrome App 20220112495 - Van Sint Fiet; Lenka ; et al. | 2022-04-14 |
| Antisense Oligonucleotides For The Treatment Of Leber`s Congenital Amaurosis App 20220098584 - Swildens; Jim ; et al. | 2022-03-31 |
| Antisense Oligonucleotides For The Treatment Of Stargardt Disease App 20210115439 - Yilmaz-Elis; Aliye Seda ; et al. | 2021-04-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 